FACULTY

Fatima Al Kaabi

Dr. Fatima Alkaabi
Vice Chair, National MS Society UAE
Executive Director, Abu Dhabi Bone Marrow Transplant Program, Abu Dhabi Stem Cells Center
Abu Dhabi, United Arab Emirates

Ghalya Alali Photo

Ms. Ghalya Al Ali
Founding Member
National Multiple Sclerosis Society UAE
Abu Dhabi, United Arab Emirates

Paulina Arce Casillas

Paulina Arce Casillas
Senior Organisational Development and Movement Building Manager
MS International Federation (MSIF)
London, United Kingdom

Raed-Al-Roughani-Image

Dr. Raed Alroughani
Consultant Neurologist, Director of MS Clinic
Amiri and Ibn Sina Hospitals
Kuwait City, Kuwait

NAJOUA ELABKARI Image

Ms. Najoua El Abkari
President, HANASEP
Rabat, Morocco

Yasmeen-Mitwally-Image

Ms. Yasmin Mitwally
Research and Advocacy Manager
National Multiple Sclerosis Society UAE
Abu Dhabi, United Arab Emirates

Zoe Burr

Ms. Zoe Burr
Head of Organisational Development and Movement Building
MS International Federation (MSIF)
Liverpool, United Kingdom

Tim Coeatzee Image

Dr. Tim Coetzee
Chief Advocacy, Services & Science Officer
US National MS Society
New York, United States of America

Joanna Laurson Image

Ms. Joanna Laurson-Doube
International Consultant - Access to Healthcare
Hong Kong, SAR China , Hong Kong

Douna Haj Ahmed

Ms. Douna Haj Ahmed
Organisational Development and Movement Building Officer
MS International Federation (MSIF)
London, United Kingdom

Ahmed Shatila Image

Dr Ahmed Shatila
Consultant Neurologist, Chairman of Medical Advisory Committee
Sheikh Shakhbout Medical City, National Multiple Sclerosis Society UAE
Abu Dhabi, United Arab Emirates

Bassem Yamout Image

Prof. Bassem I. Yamout
President, Professor of Neurology, Director, Neurology Institute
American University of Beirut, Harley Street Medical Center
Abu Dhabi, United Arab Emirates

Maya Zeineddine Image

Dr. Maya Zeineddine
Research Manager
Neurology Institute at Harley Street Medical Center
Abu Dhabi, United Arab Emirates

PROGRAM

09:00-10:45SESSION 1Chair: Joelle Massouh
09:00-09:10Welcome and IntroductionF. Alkaabi (AE)
09:10-09:30Keynote: Overview of the National MS Society UAEF. Alkaabi (AE)
09:30-09:50Improving Access to Information in the UAE and the Wider RegionG. Al Ali (AE)
09:50-10:15Q&A with the National MS Society UAEModerated by F. Alkaabi (AE) & G. Al Ali (AE)
10:15-10:45Coffee Break
10:45-12:15Session II: Key Research UpdatesChair: Z. Burr (UK)
10:45-11:15Overview of the Progressive MS Alliance T. Coetzee (US)
11:15-12:15Key Research Updates from the MENACTRIMS Congress 2023R. Alroughani (KW)
12:15-14:00Lunch Break
14:00-15:30Session III: Access to MS TreatmentsChair: J. Laurson-Doube (UK)
14:00-14:30MENA Access to Treatment CharterD.H. Ahmed (UK) & P. Arce-Casillas (UK)
14:30-15:15Using MSIF and MENACTRIMS Advocacy ToolsB. Yamout (AE)
15:15-15:30Case Study from Lebanon: How to use the WHO EML to get access to a wider range of DMTsM. Zeineddine (LB)
15:30-16:00Coffee Break
16:00 - 17:00Session IV: Access to MS TreatmentsChair: J. Laurson-Doube (UK)
16:00 -16:15Case Study from UAE: Developing National Treatment GuidelinesA. Shatila (AE) & Y. Mitwally (AE)
16:15-16:30Case Study from Morocco: How to use the WHO EML to cover the cost of MS treatment by the health systemN. El Abkari (MA)
16:30-17:00Q&AModerated by J. Laurson-Doube (UK)

TARGET AUDIENCE

MS clinicians interested in learning more about and working with MS organisations, MS organisation representatives.

REGISTRATION

Registration is possible only for those that have registered for the congress only.